Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F3UKF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,783
Award facts
- Contract value 100% obligated
- $10,782.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 26, 2026, for 90 tablets of Gemtesa 75 mg, with a ceiling value of $10,782.74. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 27, 2026. The award represents a task order under Amerisourcebergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2031 that supports military healthcare programs globally.
Gemtesa (mirabegron) is a prescription medication used in the treatment of overactive bladder, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing requirements for specialized pharmaceutical products to support military treatment facilities and veteran healthcare programs. This delivery order exemplifies the operational efficiency of the pharmaceutical prime vendor model, where Cencora and its subsidiary Amerisourcebergen leverage their comprehensive IDC to fulfill targeted medical supply needs across the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26F3UKF?
SPE2DR26F3UKF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F3UKF worth?
The government has obligated $10,783 on SPE2DR26F3UKF.
Is contract SPE2DR26F3UKF an order under another contract?
Yes. SPE2DR26F3UKF is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3UKF competed?
The extent of competition for SPE2DR26F3UKF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award